Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura, Knopp"'
Publikováno v:
IFAC-PapersOnLine. 54:478-483
Non-invasive, continuous Endogenous glucose production (EGP) estimation during exercise would help manage and automate insulin and glucose dosing during exercise, providing novel information to more effectively close the loop in managing glucose leve
Autor:
James Geoffrey Chase, Azrina Ralib, Normy Norfiza Abdul Razak, Athirah Abdul Razak, Ummu Kulthum Jamaludin, Jennifer Laura Knopp, Mohd Basri Mat Nor, Asma Abu-Samah, Christopher G. Pretty, Fatanah M. Suhaimi
Publikováno v:
Medical Devices: Evidence and Research. 13:139-149
Purpose: This paper presents an assessment of an automated and personalized stochastic targeted (STAR) glycemic control protocol compliance in Malaysian intensive care unit (ICU) patients to ensure an optimized usage. Patients and Methods: STAR propo
Autor:
Timothy Lewis, Cannon, Laura, Knopp, Hongkun, Wang, Tiffani, DeMarco, John Milburn, Jessup, Jamie, Randall, Erica, Kim, Donald L, Trump
Publikováno v:
Current Problems in Cancer. 46:100860
Patient engagement in medical decision-making improves patient related outcomes through compliance and patient satisfaction. The Inova Schar Cancer Institute has a weekly molecular tumor board (MTB) to match comprehensive genomic sequencing results w
Autor:
Hongkun Wang, Laura Knopp, Timothy L. Cannon, Donald L. Trump, Tiffani A. DeMarco, John M. Jessup
Publikováno v:
Journal of Clinical Oncology. 37:e18001-e18001
e18001 Background: Patient engagement in medical decision-making improves patient related outcomes through compliance and patient satisfaction. The Inova Schar Cancer Institute (ISCI) has a weekly molecular tumor board (MTB) to match comprehensive ge
Autor:
John M. Jessup, Anam Asif, Sheryl Krevsky Elkin, Jennifer L. Carter, Timothy L. Cannon, Laura Knopp, Donald L. Trump, Jo-Ellen Murphy
Publikováno v:
Journal of Clinical Oncology. 36:483-483
483 Background: Inova Schar Cancer Institute formed a molecular tumor board in early 2016 to identify treatment options for patients with gastrointestinal malignances based on molecular testing and to track outcomes. Methods: From March 2016 to June
Autor:
Megan Kokon, Sekwon Jang, Christina Gustavson, Andrea Finlay, Laura Knopp, Emily Hidalgo, Chiara Pierattini, Josefina Buras, Donald L. Trump, Natalia Romanova, Pamela Radomsky, John F. Deeken, Marian Daye, Jenny Fuentes, Jennifer A. DeSimone, Suraj S. Venna, Suvarna Sundaram
Publikováno v:
Journal of Clinical Oncology. 34:91-91
91 Background: Although advance care planning and the completion of advance directives (ADs) are important methods to prevent unwanted aggressive care once patients have lost their decision-making capacity, only a minority of patients have ADs at the